Trastuzumab deruxtecan

Enhertu 100 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 18 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EnhertuEuropean UnionAuthorised

EnhertuBrazil · Daiichi Sankyo Brasil Farmacêutica LtdaSame brand
EnhertuCanada · 100 MG / VIAL · Powder For Solution · Astrazeneca Canada INCSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe GmbhSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe GmbhSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para Perfusion

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Trastuzumab deruxtecan

Enhertu 100 mg, poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 18 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EnhertuEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Spain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe Gmbh

EnhertuEuropean Union · Daiichi Sankyo Europe GmbH

EnhertuCroatia

EnhertuItaly · Polvere per concentrato per soluzione per infusione · Daiichi Sankyo Europe GMBH

EnhertuItaly · Polvere per concentrato per soluzione per infusione · New Pharmashop S.R.L.

EnhertuItaly · Polvere per concentrato per soluzione per infusione · Abacus Medicine A/S

EnhertuNew Zealand · Inj 100 mg per ml, 1 ml vial

Enhertu®Serbia · 100mg · prašak za koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited Beograd

Enhertu Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100 mg/vial · infusion, solution concentrate · Astrazeneca Singapore Pte LTD

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Trastuzumab deruxtecan
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 18 Jan 2021
Registration: EU/1/20/1508
Marketing authorisation holder: Daiichi Sankyo Europe GmbH
ATC code: L01FD04
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005124
EU number: EU/1/20/1508